Published in Indian J Med Res on February 01, 2013
Vam3, a resveratrol dimer, inhibits cigarette smoke-induced cell apoptosis in lungs by improving mitochondrial function. Acta Pharmacol Sin (2014) 0.83
Vitamin D-binding protein gene polymorphisms and chronic obstructive pulmonary disease susceptibility: A meta-analysis. Biomed Rep (2014) 0.79
SCGB3A2 Inhibits Acrolein-Induced Apoptosis through Decreased p53 Phosphorylation. Acta Histochem Cytochem (2015) 0.77
Role of oxidative stress & transient receptor potential in chronic obstructive pulmonary disease. Indian J Med Res (2015) 0.75
Activity of α1-antitrypsin and some lysosomal enzymes in the blood serum of patients with chronic obstructive pulmonary disease after smoking cessation. Biomed Res Int (2015) 0.75
Study the association of chronic obstructive pulmonary disease with early endothelial dysfunction and its impact on cardiovascular system by estimating urinary albumin creatinine ratio. Lung India (2017) 0.75
Electronic health records and improved nursing management of chronic obstructive pulmonary disease. Patient Prefer Adherence (2015) 0.75
Anesthetic considerations in the patients of chronic obstructive pulmonary disease undergoing laparoscopic surgeries. Anesth Essays Res (2016) 0.75
The Anti-inflammatory Effect of Alpha-1 Antitrypsin in Rhinovirus-infected Human Airway Epithelial Cells. J Clin Cell Immunol (2016) 0.75
The effect of home-based inspiratory muscle training on exercise capacity, exertional dyspnea and pulmonary function in COPD patients. Iran J Nurs Midwifery Res (2015) 0.75
Increased serum TRAIL and DR5 levels correlated with lung function and inflammation in stable COPD patients. Int J Chron Obstruct Pulmon Dis (2015) 0.75
Recognition of Small Airways Obstruction in Asthma and COPD - The Road Less Travelled. J Clin Diagn Res (2017) 0.75
Anaesthesia for patient with chronic obstructive pulmonary disease. Indian J Anaesth (2015) 0.75
Protective effect of autophagy on endoplasmic reticulum stress-induced apoptosis of alveolar epithelial cells in rat models of COPD. Biosci Rep (2017) 0.75
Hydrogen Sulfide Inhibits Cigarette Smoke-Induced Endoplasmic Reticulum Stress and Apoptosis in Bronchial Epithelial Cells. Front Pharmacol (2017) 0.75
Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med (2007) 19.86
A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med (2008) 17.19
Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J (2004) 16.84
Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med (2010) 15.07
The natural history of chronic airflow obstruction. Br Med J (1977) 13.04
Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial. Lancet (2003) 10.97
Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA (1994) 10.46
A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med (2003) 10.40
International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet (2007) 10.12
Azithromycin for prevention of exacerbations of COPD. N Engl J Med (2011) 8.66
Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax (1999) 8.63
Chronic obstructive pulmonary disease. N Engl J Med (2000) 8.23
Development and first validation of the COPD Assessment Test. Eur Respir J (2009) 8.06
Tiotropium versus salmeterol for the prevention of exacerbations of COPD. N Engl J Med (2011) 7.92
Body-mass index and mortality in Korean men and women. N Engl J Med (2006) 7.50
Site and nature of airway obstruction in chronic obstructive lung disease. N Engl J Med (1968) 7.13
Global burden of COPD: systematic review and meta-analysis. Eur Respir J (2006) 7.00
A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci. PLoS Genet (2009) 6.93
Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the Medical Research Council Working Party. Lancet (1981) 6.48
Chronic obstructive pulmonary disease in non-smokers. Lancet (2009) 6.41
Systemic manifestations and comorbidities of COPD. Eur Respir J (2009) 5.90
Patients at high risk of death after lung-volume-reduction surgery. N Engl J Med (2001) 5.76
Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med (2011) 5.69
Effectiveness of pneumococcal polysaccharide vaccine in older adults. N Engl J Med (2003) 5.60
Pulmonary arterial enlargement and acute exacerbations of COPD. N Engl J Med (2012) 5.54
The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med (1994) 5.38
Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res (2010) 5.17
Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease. N Engl J Med (2003) 5.12
Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group. Ann Intern Med (1980) 4.81
Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1999) 4.74
Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group. N Engl J Med (1999) 4.66
Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function. Nat Genet (2009) 4.56
Retinoic acid treatment abrogates elastase-induced pulmonary emphysema in rats. Nat Med (1997) 4.45
Chronic obstructive pulmonary disease. Lancet (2012) 4.43
The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest (2005) 4.41
Smoking and lung function of Lung Health Study participants after 11 years. Am J Respir Crit Care Med (2002) 4.27
Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med (2011) 4.16
"Sick of Smoking": evaluation of a targeted minimal smoking cessation intervention in general practice. Med J Aust (1990) 4.11
Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J (2008) 4.11
Genome-wide association study identifies five loci associated with lung function. Nat Genet (2009) 4.10
MMP12, lung function, and COPD in high-risk populations. N Engl J Med (2009) 3.96
An official American Thoracic Society public policy statement: Novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2010) 3.92
Alveolar wall apoptosis causes lung destruction and emphysematous changes. Am J Respir Cell Mol Biol (2003) 3.83
Developing COPD: a 25 year follow up study of the general population. Thorax (2006) 3.72
Bronchoscopic lung-volume reduction with Exhale airway stents for emphysema (EASE trial): randomised, sham-controlled, multicentre trial. Lancet (2011) 3.70
Bronchodilator reversibility testing in chronic obstructive pulmonary disease. Thorax (2003) 3.62
Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers. Am J Respir Crit Care Med (2011) 3.58
Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. International COPD Study Group. Lancet (1998) 3.56
Resistance of central and peripheral airways measured by a retrograde catheter. J Appl Physiol (1967) 3.53
Risk of COPD from exposure to biomass smoke: a metaanalysis. Chest (2010) 3.46
Variants in FAM13A are associated with chronic obstructive pulmonary disease. Nat Genet (2010) 3.44
The definition of emphysema. Report of a National Heart, Lung, and Blood Institute, Division of Lung Diseases workshop. Am Rev Respir Dis (1985) 3.21
Passive smoking exposure and risk of COPD among adults in China: the Guangzhou Biobank Cohort Study. Lancet (2007) 3.12
Effect of bronchoscopic lung volume reduction on dynamic hyperinflation and exercise in emphysema. Am J Respir Crit Care Med (2004) 3.10
Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1998) 3.09
Matrix metalloproteinase-9 in lung remodeling. Am J Respir Cell Mol Biol (2003) 2.95
Lung cancer in patients with chronic obstructive pulmonary disease-- incidence and predicting factors. Am J Respir Crit Care Med (2011) 2.93
Prevalence of pulmonary embolism in acute exacerbations of COPD: a systematic review and metaanalysis. Chest (2008) 2.93
Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. Ann Epidemiol (2005) 2.92
Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial. Lancet (1999) 2.90
Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort. Am J Respir Crit Care Med (2010) 2.80
Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. Am J Respir Crit Care Med (1997) 2.77
Radiographic emphysema predicts low bone mineral density in a tobacco-exposed cohort. Am J Respir Crit Care Med (2010) 2.60
Cellular and structural bases of chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2001) 2.58
Once-daily bronchodilators for chronic obstructive pulmonary disease: indacaterol versus tiotropium. Am J Respir Crit Care Med (2010) 2.56
Long-term follow-up of patients receiving lung-volume-reduction surgery versus medical therapy for severe emphysema by the National Emphysema Treatment Trial Research Group. Ann Thorac Surg (2006) 2.53
Role of apoptosis in the pathogenesis of COPD and pulmonary emphysema. Respir Res (2006) 2.40
Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care. Thorax (2010) 2.26
COPD in China: the burden and importance of proper management. Chest (2011) 2.22
Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2012) 2.21
Indian study on epidemiology of asthma, respiratory symptoms and chronic bronchitis in adults (INSEARCH). Int J Tuberc Lung Dis (2012) 2.20
Prevalence and clinical correlates of bronchoreversibility in severe emphysema. Eur Respir J (2009) 2.18
Circulating endothelial microparticles as a measure of early lung destruction in cigarette smokers. Am J Respir Crit Care Med (2011) 2.12
Standardizing measurement of chronic obstructive pulmonary disease exacerbations. Reliability and validity of a patient-reported diary. Am J Respir Crit Care Med (2010) 2.09
The electrophoretic α1-globulin pattern of serum in α1-antitrypsin deficiency. 1963. COPD (2013) 2.06
Lifetime environmental tobacco smoke exposure and the risk of chronic obstructive pulmonary disease. Environ Health (2005) 2.04
Impact of exacerbations on emphysema progression in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2011) 2.03
Skeletal muscle apoptosis and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2002) 2.01
Once-daily indacaterol versus twice-daily salmeterol for COPD: a placebo-controlled comparison. Eur Respir J (2010) 2.01
Salmeterol plus theophylline combination therapy in the treatment of COPD. Chest (2001) 2.01
Roflumilast with long-acting β2-agonists for COPD: influence of exacerbation history. Eur Respir J (2011) 1.99
A genome-wide association study of COPD identifies a susceptibility locus on chromosome 19q13. Hum Mol Genet (2011) 1.98
Reported pneumonia in patients with COPD: findings from the INSPIRE study. Chest (2010) 1.93
Acute respiratory illness in patients with COPD and the effectiveness of influenza vaccination: a randomized controlled study. Chest (2004) 1.89
Treatment of cachexia with ghrelin in patients with COPD. Chest (2005) 1.87
Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: a meta-analysis. Arch Intern Med (2009) 1.86
Haemoglobin level and its clinical impact in a cohort of patients with COPD. Eur Respir J (2007) 1.85
Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD. Chest (2005) 1.83
Respiratory disease associated with solid biomass fuel exposure in rural women and children: systematic review and meta-analysis. Thorax (2011) 1.80
Elastin fragments attract macrophage precursors to diseased sites in pulmonary emphysema. Science (1981) 1.80
The pathogenesis of chronic obstructive pulmonary disease: advances in the past 100 years. Am J Respir Cell Mol Biol (2005) 1.78
Lung function and ischemic stroke incidence: the Atherosclerosis Risk in Communities study. Chest (2006) 1.78
A multicentric study on epidemiology of chronic obstructive pulmonary disease and its relationship with tobacco smoking and environmental tobacco smoke exposure. Indian J Chest Dis Allied Sci (2006) 1.78
Disease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbations. Eur Respir J (2003) 1.70
Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1996) 1.69
Systematic review with meta-analysis of the epidemiological evidence relating smoking to COPD, chronic bronchitis and emphysema. BMC Pulm Med (2011) 1.65
Efficacy and safety of indacaterol 150 microg once-daily in COPD: a double-blind, randomised, 12-week study. BMC Pulm Med (2010) 1.64
Previous lung diseases and lung cancer risk: a systematic review and meta-analysis. PLoS One (2011) 1.62
Chronic obstructive pulmonary disease and long-term exposure to traffic-related air pollution: a cohort study. Am J Respir Crit Care Med (2010) 1.62
Tropical parasitic lung diseases. Indian J Chest Dis Allied Sci (2008) 1.16
Miliary tuberculosis & its sequelae. Indian J Med Res (2007) 0.75